TRANSITION THERAPEUTICS INC (CANADA)
TTHI
TTHI was delisted on the 30th of August, 2016.
2 hedge funds and large institutions have $319K invested in TRANSITION THERAPEUTICS INC (CANADA) in 2016 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 18 closing their positions.
90% less funds holding
Funds holding: 20 → 2 (-18)
98% less capital invested
Capital invested by funds: $14.7M → $319K (-$14.4M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 18
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$7.65M |
| 2 |
OIM
Oracle Investment Management
Greenwich,
Connecticut
|
-$5.61M |
| 3 |
Renaissance Technologies
New York
|
-$414K |
| 4 |
BC
Birchview Capital
Burlington,
Vermont
|
-$193K |
| 5 |
FNBT
FineMark National Bank & Trust
Fort Myers,
Florida
|
-$169K |
TTHI Hedge Fund Activity: Q3 2016 in Review
2 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in TRANSITION THERAPEUTICS INC (CANADA) (TTHI) for Q3 2016, worth a combined $319K — down 98% from $14.7M a quarter earlier.
Sellers outnumbered buyers: 18 funds closed out of TTHI and 0 opened new positions — a net loss of 18 holders — while 1 trimmed existing stakes and 0 added.
The largest seller was Fidelity Investments, exiting entirely with an estimated $7.65M sold.
- 2 institutional investors held TRANSITION THERAPEUTICS INC (CANADA) (TTHI) as of Q3 2016, down from 20 in Q2 2016.
- Funds reported $319K of TRANSITION THERAPEUTICS INC (CANADA) stock for Q3 2016, down 98% quarter-over-quarter.
- 0 funds opened new TRANSITION THERAPEUTICS INC (CANADA) positions in Q3 2016 and 18 closed out, a net change of -18 holders.
- The largest TRANSITION THERAPEUTICS INC (CANADA) seller in Q3 2016 was Fidelity Investments, an estimated $7.65M sold.
Based on aggregated 13F filings for Q3 2016.